Dr. Reddy's Laboratories Limited
RDYHealthcare|Drug Manufacturers - Specialty & Generic|IN
$14.91
+0.38 (+2.62%)
DCF Value
$14.42
Tangible Book / Share
$326.68
Graham Number
$591.75
Cash / Share
$91.49
Clinical Trials (239)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07475572 Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma | Melanoma | P1 | Recruiting | 120 | RCT, Double-blind | AVT32-DRL_PB, Keytruda |
| NCT00404989 Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. | HIV Infections, Hepatitis B | Recruiting | 24,258 | — | — | |
| NCT02638831 Ketorol Gel in Gonarthrosis and Low Back Pain | Gonarthrosis, Low Back Pain | P4 | Completed | 240 | RCT, Open-label | Ketorolac Tromethamine, Ketoprofen |
| NCT03160807 Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections | Urinary Tract Infection | P4 | Unknown | 214 | RCT, Open-label | Levofloxacin, Levofloxacin |
| NCT02922699 Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases | GERD | P4 | Completed | 120 | RCT, Open-label | OMEZ 40, OMEZ 80 |
| NCT02301962 Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer | Cancer | P4 | Unknown | 58 | Open-label | Panitumumab |
| NCT02140073 Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity | GERD | P4 | Unknown | 60 | RCT, Single-blind | omeprazole+domperidone SR, omeprazole |
| NCT02922712 Evaluation of the Efficacy and Safety of Nise 100 mg in the Management of Osteoarthrosis (Gonarthrosis) | Knee Osteoarthritis | P4 | Completed | 202 | Open-label | NISE |
| NCT01871727 A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma | Persistent or Recurrent Cutaneous T-Cell Lymphoma | P3 | Completed | 112 | Open-label | E7777 9 mcg/kg |
| NCT04529499 Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients | Covid19 | P3 | Terminated | 353 | RCT, Double-blind | AVIGAN, Placebo Comparator |
| NCT02572986 A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies | Scabies | P3 | Completed | 250 | RCT, Double-blind | Permethrin |
| NCT03290027 A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris | Acne Vulgaris | P3 | Completed | 550 | RCT, Double-blind | DFD-03 |
| NCT05343455 A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2) | Papulopustular Rosacea | P3 | Completed | 330 | RCT, Double-blind | DFD-29, Doxycycline, Placebo |
| NCT03009019 Efficacy, Tolerability, and Safety of DFN-15 | Migraine Headache | P3 | Completed | 631 | RCT, Double-blind | DFN-15 Active |
| NCT02060903 A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation | Head Lice Infestation | P3 | Completed | 379 | RCT, Double-blind | Abametapir Lotion 0.74% w/w, Vehicle Lotion |
| NCT01402024 Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children and Adolescent Receiving Chemotherapy | Chemotherapy Induced Nausea and Vomiting | P3 | Completed | 96 | RCT, Double-blind | Aprepitant, Placebo |
| NCT05296629 A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea. | Papulopustular Rosacea | P3 | Completed | 323 | RCT, Double-blind | DFD-29, Doxycycline, Placebo |
| NCT02062060 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation | Head Lice Infestation | P3 | Completed | 325 | RCT, Double-blind | Abametapir Lotion 0.74% w/w, Vehicle Lotion |
| NCT02279082 DFN-02 Open Label Safety Study in Patients With Acute Migraine | Acute Migraine | P3 | Completed | 167 | Open-label | DFN-02 |
| NCT03116698 A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period | Actinic Keratosis (AK) | P2P3 | Completed | 240 | RCT, Double-blind | Low dose DFD07 once daily, High dose DFD07 once daily, High dose DFD07 twice daily, Placebo twice daily |
| NCT04640233 Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection | COVID-19 Prevention | P2P3 | Unknown | 1,600 | RCT, Double-blind | Gam-COVID-Vac |
| NCT01674530 Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation | Chronic Idiopathic Constipation | P3 | Completed | 909 | RCT, Double-blind | Lubiprostone, Lubiprostone, Placebo |
| NCT03976102 Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma | Follicular Lymphoma | P3 | Completed | 317 | RCT, Double-blind | DRL_RI (Proposed rituximab biosimilar) |
| NCT03292640 A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks | Acne Vulgaris | P3 | Completed | 547 | RCT, Double-blind | DFD-03 (0.1% tazarotene) Lotion, DFD-03 (0% tazarotene) Lotion (Placebo) |
| NCT02569853 DFN-11 Injection in Episodic Migraine With or Without Aura | Episodic Migraine | P3 | Completed | 268 | RCT, Double-blind | DFN-11 |
| NCT01057537 UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events | Cardiovascular Diseases | P3 | Completed | 2,004 | RCT, Open-label | polypill, Usual cardiovascular medications |
| NCT04268771 A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products | Rheumatoid Arthritis | P3 | Completed | 140 | RCT, Double-blind | Experimental: Arm A: DRL_RI, Arm B: Rituxan®/Mabthera® |
| NCT03340961 A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules | Rosacea | P2 | Completed | 205 | RCT, Double-blind | DFD-29 Extended Release Capsules (40 mg), DFD-29 Extended Release Capsules (20 mg), Oraycea® (doxycycline) Capsules, Placebo Capsules |
| NCT01496352 DFA-02 in Patients Undergoing Colorectal Surgery | Surgical Site Infection | P1P2 | Completed | 30 | RCT, Double-blind | DFA-02, Placebo |
| NCT02173301 A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis | Psoriasis | P2 | Completed | 200 | RCT, Double-blind | XP23829 400 mg QD, XP 23829 800 mg QD, XP23829 400 mg BID, Placebo |
| NCT01559545 A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis | Clostridium Difficile Associated Diarrhea | P2 | Completed | 60 | RCT, Open-label | Metronidazole, Metronidazole-DRF1, Metronidazole-DRF2 |
| NCT02097485 Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation | Head Lice Infestation | P2 | Completed | 50 | RCT, Double-blind | Abametapir Lotion 0.74% w/w, Vehicle Lotion |
| NCT03341910 A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris | Acne Vulgaris | P2 | Completed | 155 | RCT, Double-blind | DFD-03 Lotion, 0.1%, Tazorac Cream, 0.1%, DFD-03 Vehicle Lotion 0%, Tazorac Vehicle Cream 0% |
| NCT02583425 Pilot Study of DFN-11 Injection in Medication Overuse Headache | Medication Overuse Headache | P2 | Terminated | 27 | Open-label | DFN-11 Injection |
| NCT03472378 Can DFN-15 Terminate Migraine With Allodynia? | Migraine With Aura, Migraine Without Aura | P2 | Completed | 51 | RCT, Double-blind | DFN-15 |
| NCT01907490 Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation | Head Lice Infestation | P2 | Completed | 38 | Open-label | Ha44 Gel |
| NCT02571049 Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine | Rapidly Escalating Migraine | P2 | Completed | 24 | RCT, Double-blind | DFN-11 |
| NCT03554772 Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15 | Acute Pain | P2 | Completed | 120 | RCT, Double-blind | DFN-15 (Celecoxib Oral Solution) 62.5 mg, DFN-15 (Celecoxib Oral Solution) 125 mg, DFN-15 (Celecoxib Oral Solution) 250 mg, Placebo |
| NCT03599193 A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris | Acne Vulgaris | P2 | Completed | 58 | RCT, Single-blind | Tazarotene Lotion, 0.1%, Tazarotene Cream, 0.1% |
| NCT02010333 A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation | Head Lice Infestation | P2 | Completed | 22 | Open-label | Ha44 Gel 0.74% w/w |
| NCT02472418 Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches | Migraine | P2 | Completed | 63 | RCT, Double-blind | DFN-15 Dose A (treatment A), DFN-15 Dose B (treatment B) |
| NCT03421197 A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) | Psoriasis | P2 | Completed | 426 | RCT, Double-blind | PPC-06 400 mg QD, PPC-06 400 mg BID, PPC-06 600 mg, Placebo |
| NCT01336647 An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation | Pediculosis | P2 | Completed | 142 | RCT, Double-blind | Group A - Low-Dose Ha44 0.37% w/w, Group B - High Dose Ha44 Gel 0.74% w/w, Group C - Placebo |
| NCT02296775 Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis | Rheumatoid Arthritis | P1P2 | Completed | 276 | RCT, Double-blind | DRL_RI, Rituxan, MabThera |
| NCT01388816 A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels | Type II Hyperlipidemia | P2 | Completed | 176 | RCT, Double-blind | DRL-17822 or placebo |
| NCT02828241 A Study to Assess the Efficacy, Safety and Tolerability of DFD-04 | Rosacea | P2 | Completed | 61 | RCT, Double-blind | DFD-04 Ointment |
| NCT01888367 Safety, Efficacy and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery | Surgical Site Infections | P2 | Completed | 445 | RCT, Double-blind | DFA-02 Antibiotic Gel, DFA-02 Placebo Gel |
| NCT01581788 Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed Conditions | Healthy | P1 | Completed | 54 | RCT, Open-label | Divalproex Sodium |
| NCT01170182 Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed Condition | Healthy | P1 | Completed | 54 | RCT, Open-label | Omeprazole |
| NCT01164761 Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited Under Fasting Conditions | Healthy | P1 | Completed | 54 | RCT, Open-label | Ramipril, Altace |
| NCT02061813 Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion | Head Lice | P1 | Completed | 40 | RCT, Double-blind | Abametapir Lotion 0.74% w/w, Sodium Lauryl Sulfate, Saline 0.9%, Placebo |
| NCT01621763 Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions | Healthy | P1 | Completed | 68 | RCT, Open-label | Clopidogrel |
| NCT01581879 Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions | Healthy | P1 | Completed | 38 | RCT, Open-label | Ziprasidone Hydrochloride |
| NCT06126042 Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route | Rheumatoid Arthritis | P1 | Unknown | 330 | RCT, Double-blind | Test Product, Reference product, Reference Medicinal Product |
| NCT01064271 Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition | Healthy | P1 | Completed | 26 | RCT, Open-label | Risperidone |
| NCT01052129 Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fasting Condition | Healthy | P1 | Completed | 26 | RCT, Open-label | Naproxen sodium |
| NCT01503450 Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition | Fed | P1 | Completed | 26 | RCT, Open-label | Olanzapine OD Tablets 5 mg |
| NCT01052792 Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fed Conditions | Healthy | P1 | Completed | 26 | RCT, Open-label | Naproxen Sodium |
| NCT01503424 Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study | Fed | P1 | Completed | 48 | RCT, Open-label | Olanzapine |
| NCT01131897 Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fasting Conditions. | Healthy | P1 | Completed | 24 | RCT, Open-label | Levetiracetam |
| NCT01155947 Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 36 | RCT, Open-label | Anastrozole |
| NCT01161134 Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition | Healthy | P1 | Completed | 28 | RCT, Open-label | Meloxicam |
| NCT01314339 Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions. | Fasting | P1 | Completed | 28 | RCT, Open-label | Desloratadine |
| NCT01511705 Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fasting Condition | Healthy | P1 | Completed | 26 | RCT, Open-label | Ondansetron Hydrochloride, Ondansetron Hydrochloride |
| NCT01131988 Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 40 | RCT, Open-label | Tacrolimus Capsules |
| NCT01264302 Bioequivalence Study of Two Finasteride 5 mg Tablet Formulations Under Non-Fasting Conditions | Healthy | P1 | Completed | 26 | RCT, Open-label | Finasteride |
| NCT01065987 Bioequivalence Study of Tizanidine HCl 4mg Tablets of Dr.Reddy's Under Fed Conditions | Healthy | P1 | Completed | 24 | RCT, Open-label | Tizanidine |
| NCT01888224 Bioavailability Study of Isotretinoin Capsules 40 mg Under Fed Condition | Healthy | P1 | Completed | 61 | RCT, Open-label | Isotretinoin |
| NCT01131780 Bioequivalency Study of Ibuprofen 200 mg and Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 32 | RCT, Open-label | Ibuprofen + Pseudoephedrine Hydrochloride |
| NCT01133457 Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition | Healthy | P1 | Completed | 24 | RCT, Open-label | Finasteride |
| NCT02296723 Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed Condition | Healthy | P1 | Completed | 66 | RCT, Open-label | Valganciclovir Hydrochloride |
| NCT01506076 Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fasting Conditions | Fasting | P1 | Completed | 29 | RCT, Open-label | Levocetirizine DiHCl |
| NCT02205320 A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers | Pharmacokinetics | P1 | Unknown | 192 | RCT, Double-blind | DRL_PG, Pegfilgrastim Form A, Pegfilgrastim Form B |
| NCT01372358 Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting Conditions | Fed | P1 | Completed | 32 | RCT, Open-label | CIPRO®XR |
| NCT01161927 Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Non- Fasting Conditions | Healthy | P1 | Completed | 26 | RCT, Open-label | Nizatidine, Axid |
| NCT01372280 Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition | Fasting | P1 | Completed | 28 | RCT, Open-label | Reminyl |
| NCT01506063 Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fed Conditions | Healthy | P1 | Completed | 31 | RCT, Open-label | Levocetirizine DiHCl |
| NCT01513720 Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition | Healthy | P1 | Completed | 20 | RCT, Open-label | Lamotrigine, Lamictal® |
| NCT01045642 Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsules Under Fasting Conditions | Healthy | P1 | Completed | 38 | RCT, Open-label | Omeprazole |
| NCT01267396 Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg Under Fasting Conditions | Healthy | P1 | Completed | 32 | RCT, Open-label | Sertraline |
| NCT01164800 Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fed Conditions | Healthy | P1 | Completed | 52 | RCT, Open-label | Trandolapril, Mavik |
| NCT01146041 Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions | Healthy | P1 | Completed | 44 | RCT, Open-label | Rivastigmine |
| NCT01267383 Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg in Fed Conditions | Healthy | P1 | Completed | 32 | RCT, Open-label | Sertraline |
| NCT01133470 Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr. Reddy's and Allegra D 24 Hour ER Tablets Under Fasting Conditions | Healthy | P1 | Completed | 54 | RCT, Open-label | Fexofenadine HCl + Pseudoephedrine HCl |
| NCT01149980 Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions | Healthy | P1 | Completed | 24 | RCT, Open-label | Citalopram Hydrobromide |
| NCT01283061 Bioequivalence Study of Zafirlukast Tablets 20 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition | Healthy | P1 | Completed | 44 | RCT, Open-label | Zafirlukast |
| NCT01149941 Bioequivalence Study of Ibuprofen 200 mg Gel Capsules of Dr. Reddy's Laboratories Under Fasting Condition | Healthy | P1 | Completed | 30 | RCT, Open-label | Ibuprofen |
| NCT01286701 Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fed Conditions | Healthy | P1 | Completed | 18 | RCT, Open-label | Terbinafine Hydrochloride Tablets, 250 mg |
| NCT01132196 Bioequivalence Study of Divalproex Sodium DR Tablets 500 mg of Dr. Reddy's Under Fed Conditions | Healthy | P1 | Completed | 34 | RCT, Open-label | Divalproex Sodium |
| NCT02292069 Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition | Healthy | P1 | Completed | 90 | RCT, Open-label | Amlodipine besylate/Atorvastatin calcium |
| NCT01691456 Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fasting Condition | Healthy | P1 | Completed | 45 | RCT, Open-label | Montelukast sodium |
| NCT03282838 Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects | Migraine | P1 | Completed | 24 | RCT, Open-label | DFN-15 (fasted), DFN-15 (fed), Comparator Celebrex® (fed) |
| NCT01506791 Bioequivalence Study of Desloratadine and Pseudoephedrine Extended-release Tablets Under Fed Conditions | Healthy | P1 | Completed | 44 | RCT, Open-label | Desloratadine and pseudoephedrine |
| NCT01286688 Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fasting Conditions | Fasting | P1 | Completed | 36 | RCT, Open-label | Terbinafine Hydrochloride Tablets, 250 mg |
| NCT01518699 Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers | Pediculosis | P1 | Completed | 57 | RCT, Double-blind | Ha44, Ha44 Placebo, Moxifloxacin Placebo, Moxifloxacin |
| NCT01166100 Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting Condition | Healthy | P1 | Completed | 54 | RCT, Open-label | Fluoxetine Hydrochloride |
| NCT05597462 Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks | Rosacea | P1 | Completed | 60 | RCT, Double-blind | Minocycline hydrochloride capsules |
| NCT02296762 Bioavailability Study of Sirolimus Tablets 2 mg Under Fed Condition | Healthy | P1 | Completed | 36 | RCT, Open-label | Sirolimus |
| NCT01888718 Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets 30 mg Under Fasting Condition | Healthy | P1 | Completed | 80 | RCT, Open-label | Fexofenadine Hydrochloride |
| NCT01136525 Bioavailability Study of Valacyclovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 41 | RCT, Open-label | Valacyclovir Hydrochloride |
| NCT01146106 Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fasting Conditions | Healthy | P1 | Completed | 43 | RCT, Open-label | Pravastatin Sodium |
| NCT01131936 Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fed Conditions | Healthy | P1 | Completed | 24 | RCT, Open-label | Amlodipine |
| NCT01627834 Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting Condition | Healthy | P1 | Completed | 48 | RCT, Open-label | Ropinirole |
| NCT01149967 Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions | Healthy | P1 | Completed | 24 | RCT, Open-label | Citalopram Hydrobromide |
| NCT01372982 Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed Conditions | Healthy | P1 | Completed | 36 | RCT, Open-label | Letrozole |
| NCT01888328 Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fed Condition | Healthy | P1 | Completed | 26 | RCT, Open-label | Isotretinoin |
| NCT01155921 Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions | Healthy | P1 | Completed | 36 | RCT, Open-label | Risperidone Orally Disintegrating Tablets |
| NCT01131949 Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fasting Condition | Healthy | P1 | Completed | 26 | Open-label | Lamotrigine |
| NCT03706300 Bioequivalence Study of Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg Under Fasting Conditions | Healthy | P1 | Completed | 80 | RCT, Open-label | Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg |
| NCT02322645 Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting Conditions | Healthy | P1 | Completed | 46 | RCT, Open-label | Eszopiclone Tablets 3 mg |
| NCT01131728 Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER Tablets of Dr. Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 26 | RCT, Open-label | Naproxen Sodium & Pseudoephedrine HCl |
| NCT01155934 Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions | Healthy | P1 | Completed | 36 | RCT, Open-label | Risperidone Orally Disintegrating Tablets |
| NCT01064232 Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition | Healthy | P1 | Completed | 30 | RCT, Open-label | Risperidone |
| NCT01132222 Bioequivalence Study of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Under Fed Conditions | Healthy | P1 | Completed | 34 | RCT, Open-label | Ibuprofen + Pseudoephedrine Hydrochloride |
| NCT01621750 Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions | Fasting | P1 | Completed | 68 | RCT, Open-label | Clopidogrel |
| NCT02322658 Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fed Conditions | Healthy | P1 | Completed | 46 | RCT, Open-label | Eszopiclone Tablets 3 mg |
| NCT01512459 Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed Conditions | Healthy | P1 | Completed | 33 | RCT, Open-label | Venlafaxine |
| NCT01159158 Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition | Healthy | P1 | Completed | 68 | RCT, Open-label | Nateglinide |
| NCT03702855 Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fed Conditions | Healthy | P1 | Completed | 48 | RCT, Open-label | Tetrabenazine Tablets 25 mg |
| NCT01503398 Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions | Fasting | P1 | Completed | 48 | RCT, Open-label | Olanzapine |
| NCT01161966 Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions | Healthy | P1 | Completed | 26 | RCT, Open-label | Zonisamide, Zonegran |
| NCT01513681 Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition | Healthy | P1 | Completed | 20 | RCT, Open-label | Lamotrigine, Lamictal® |
| NCT01503437 Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition | Fasting | P1 | Completed | 22 | RCT, Open-label | Olanzapine OD Tablets 5 mg |
| NCT01375452 Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 36 | RCT, Open-label | Letrozole |
| NCT01164787 Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 52 | RCT, Open-label | Trandolapril, Mavik |
| NCT02260544 Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection | Ovarian Epithelial Cancer Recurrent | P1 | Completed | 49 | RCT, Open-label | Doxorubicin Hydrochloride Liposome Injection |
| NCT01155895 Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions | Healthy | P1 | Completed | 54 | RCT, Open-label | Amlodipine Besylate / Benazepril Hydrochloride |
| NCT01888289 Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fasting Condition | Healthy | P1 | Completed | 35 | RCT, Open-label | Isotretinoin |
| NCT01888341 Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting Condition | Healthy | P1 | Completed | 41 | RCT, Open-label | Isotretinoin |
| NCT01627886 Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition | Healthy | P1 | Completed | 100 | RCT, Open-label | Ibandronate sodium |
| NCT01645410 Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg of Dr. Reddy's Under Fed Conditions | Healthy | P1 | Completed | 71 | RCT, Open-label | Atorvastatin Calcium Tablets, 40 mg |
| NCT01923259 Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fed Condition | Healthy | P1 | Completed | 94 | RCT, Open-label | Donepezil |
| NCT01133444 Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition | Healthy | P1 | Completed | 24 | RCT, Open-label | Finasteride |
| NCT01511731 Bioavailability Study of Famotidine Tablets 40 mg Under Fasting Conditions | Healthy | P1 | Completed | 30 | RCT, Open-label | Famotidine, Pepcid |
| NCT01506011 Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions | Fasting | P1 | Completed | 50 | RCT, Open-label | Amlodipine Besylate/Benazepril HCl |
| NCT07744828 A Study to Evaluate Pharmacokinetics of DRL_AB in Healthy Male Participants | Healthy Volunteers | P1 | Not Yet Recruiting | 160 | RCT, Open-label | DRL_AB |
| NCT01513057 Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fed Conditions | Healthy | P1 | Completed | 61 | RCT, Open-label | Mycophenolate Mofetil, Mycophenolate Mofetil |
| NCT01674517 Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fed Condition | Healthy | P1 | Completed | 35 | RCT, Open-label | Montelukast sodium chewable tablets 4mg and 5mg |
| NCT01923558 Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Condition | Healthy | P1 | Completed | 76 | RCT, Open-label | Donepezil |
| NCT01132183 Bioequivalence Study of Divalproex Sodium Capsules(Sprinkle),125 mg of Dr. Reddy's Under Fasting Condition (Apple Sauce) | Healthy | P1 | Completed | 34 | RCT, Open-label | Divalproex Sodium |
| NCT01283932 Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed Condition | FED | P1 | Completed | 52 | RCT, Open-label | Pantoprazole Sodium |
| NCT01131702 Bioequivalency Study of Ranitidine Tablets 300 mg of Dr. Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 24 | RCT, Open-label | Ranitidine |
| NCT01131923 Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 26 | RCT, Open-label | Amlodipine |
| NCT01504516 Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed Condition | Healthy | P1 | Completed | 25 | RCT, Open-label | Donepezil Hydrochloride, Aricept |
| NCT01055938 Bioequivalence Study of Dr. Reddy's Divalproex Sodium Capsules (Sprinkle), 125 mg Under Fasting Conditions | Healthy | P1 | Completed | 34 | RCT, Open-label | Divalproex Sodium |
| NCT05452785 A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects | Pharmacokinetics | P1 | Completed | 24 | RCT, Open-label | DFD-29 (Minocycline) Fasting, DFD-29 (Minocycline) Fed, Solodyn (Minocycline) Fasting |
| NCT01506713 Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions | Fasting | P1 | Completed | 53 | RCT, Open-label | Clopidogrel |
| NCT01283919 Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition | Fasting | P1 | Completed | 42 | RCT, Open-label | Pantoprazole Sodium |
| NCT01155960 Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed Conditions | Healthy | P1 | Completed | 36 | RCT, Open-label | Anastrozole |
| NCT01645423 Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fed Conditions | Healthy | P1 | Completed | 77 | RCT, Open-label | Atorvastatin Calcium Tablets, 80 mg |
| NCT01506050 Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting Condition | Healthy | P1 | Completed | 35 | RCT, Open-label | Desloratadine |
| NCT01146093 Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fed Conditions | Healthy | P1 | Completed | 24 | RCT, Open-label | Pravastatin Sodium |
| NCT01166087 Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed Condition | Healthy | P1 | Completed | 54 | RCT, Open-label | Fluoxetine Hydrochloride |
| NCT01053338 Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fed Condition | Healthy | P1 | Completed | 40 | RCT, Open-label | Ibuprofen and Diphenhydramine Citrate |
| NCT01160029 Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fed Condition | Healthy | P1 | Completed | 58 | RCT, Open-label | Nateglinide |
| NCT01673997 Bioequivalence Study of Metoprolol Succinate ER Tablets, 200 mg Under Fasting Conditions | Healthy | P1 | Completed | 48 | RCT, Open-label | Metoprolol Succinate |
| NCT01888250 Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fasting Condition | Healthy | P1 | Completed | 36 | RCT, Open-label | Lamotrigine |
| NCT03478436 Pharmacokinetics of Doxycycline in Skin of Healthy Volunteers | Rosacea | P1 | Completed | 6 | RCT, Open-label | Doxycycline |
| NCT01136538 Bioavailability Study of Valacycovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fed Condition | Healthy | P1 | Completed | 34 | RCT, Open-label | Valacyclovir Hydrochloride |
| NCT01691469 Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fed Condition | Healthy | P1 | Completed | 31 | RCT, Open-label | Montelukast sodium |
| NCT01053689 Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablets in Healthy Subjects Under Fed Condition | Healthy | P1 | Completed | 44 | RCT, Open-label | Glimepiride tablets 1 mg |
| NCT01264289 Bioequivalence Study of Finasteride 5 mg Tablet Formulations Under Fasting Conditions | Healthy | P1 | Completed | 26 | RCT, Open-label | Finasteride |
| NCT02297854 Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition | Healthy | P1 | Completed | 83 | RCT, Open-label | Valganciclovir Hydrochloride |
| NCT01645384 Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg Under Fasting Conditions | Healthy | P1 | Completed | 69 | RCT, Open-label | Atorvastatin Calcium Tablets, 40 mg |
| NCT01581866 Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions | Healthy | P1 | Completed | 56 | RCT, Open-label | Ziprasidone Hydrochloride |
| NCT01372306 Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition | Fed | P1 | Completed | 24 | RCT, Open-label | Reminyl |
| NCT01512485 Bioequivalence Study of Clopidogrel Tablets 75 mg Under Fed Conditions | Healthy | P1 | Completed | 51 | RCT, Open-label | Clopidogrel |
| NCT01566487 Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting Condition | Healthy | P1 | Completed | 54 | RCT, Open-label | Quetiapine fumarate |
| NCT01627847 Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Condition | Healthy | P1 | Completed | 48 | RCT, Open-label | Ropinirole |
| NCT01131975 Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fed Condition | Healthy | P1 | Completed | 26 | Open-label | Lamotrigine |
| NCT01164826 Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fed Conditions | Healthy | P1 | Completed | 30 | RCT, Open-label | Nabumetone, Relafen |
| NCT02322632 Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions | Healthy | P1 | Completed | 69 | RCT, Open-label | Paricalcitol Capsules, 4 mcg |
| NCT01161979 Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions | Healthy | P1 | Completed | 26 | RCT, Open-label | Zonisamide, Zonegran |
| NCT01283841 Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Fasting Conditions | Fasting | P1 | Completed | 48 | RCT, Open-label | Mycophenolate Mofetil |
| NCT01133496 Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 80 | RCT, Open-label | Alendronate Sodium Tablets, 70 mg |
| NCT01132040 Bioequivalence Study of Primidone Tablets 50 mg of Dr. Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 24 | RCT, Open-label | Primidone |
| NCT01164774 Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions | Healthy | P1 | Completed | 54 | RCT, Open-label | Ramipril, Altace |
| NCT01052909 Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 mg Under Fasting Condition | Healthy | P1 | Completed | 44 | RCT, Open-label | Glimepiride |
| NCT01132352 Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed Conditions | Healthy | P1 | Completed | 24 | RCT, Open-label | Levetiracetam |
| NCT01645449 Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 77 | RCT, Open-label | Atorvastatin Calcium Tablets, 80 mg |
| NCT01149954 Bioequivalence Study of Ibuprofen 200 mg Soft Gel Capsules of Dr. Reddy's Laboratories Limited Under Fed Conditions | Healthy | P1 | Completed | 30 | RCT, Open-label | Ibuprofen |
| NCT01511718 Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fed Condition | Healthy | P1 | Completed | 26 | RCT, Open-label | Ondansetron Hydrochloride, Ondansetron Hydrochloride |
| NCT01160068 Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fed Condition | Healthy | P1 | Completed | 50 | RCT, Open-label | Metformin, Glucophage |
| NCT01161147 Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition | Healthy | P1 | Completed | 28 | RCT, Open-label | Meloxicam |
| NCT01314352 Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions | Fed | P1 | Completed | 28 | RCT, Open-label | Desloratadine |
| NCT01064154 Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fasting Conditions | Healthy | P1 | Completed | 36 | RCT, Open-label | Carvedilol |
| NCT01146067 Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions | Healthy | P1 | Completed | 44 | RCT, Open-label | Rivastigmine |
| NCT01167933 Bioequivalence Study of Simvastatin Tablets, 80 mg of Dr. Reddy's Under Fed Conditions | Healthy | P1 | Completed | 44 | RCT, Open-label | Simvastatin |
| NCT01066767 Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochloride 180 mg Tablets Under Fed Conditions | Healthy | P1 | Completed | 30 | RCT, Open-label | Fexofenadine |
| NCT01511757 Bioavailability Study of Fluconazole Tablets 200 mg Under Fed Conditions | Healthy | P1 | Completed | 15 | RCT, Open-label | Fluconazole, Fluconazole |
| NCT01155908 Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions | Healthy | P1 | Completed | 48 | RCT, Open-label | Amlodipine Besylate / Benazepril Hydrochloride |
| NCT01694797 Bioequivalence Study for Metoprolol Succinate ER Tablets 50 mg Under Fasting Condition | Healthy | P1 | Completed | 48 | RCT, Open-label | Metoprolol Succinate |
| NCT01066754 Bioequivalence Study of Dr.Reddy's Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions | Healthy | P1 | Completed | 44 | RCT, Open-label | Fexofenadine |
| NCT01161940 Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions | Healthy | P1 | Completed | 26 | RCT, Open-label | Nizatidine, Axid |
| NCT02296749 Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting Condition | Healthy | P1 | Completed | 60 | RCT, Open-label | Sirolimus |
| NCT01164813 Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 44 | RCT, Open-label | Nabumetone, Relafen |
| NCT01270308 Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting Conditions | Healthy | P1 | Completed | 48 | RCT, Open-label | Lansoprazole |
| NCT01064180 Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fed Conditions | Healthy | P1 | Completed | 24 | RCT, Open-label | Carvedilol |
| NCT01053208 Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fasting Condition | Healthy | P1 | Completed | 40 | RCT, Open-label | Ibuprofen and Diphenhydramine Citrate |
| NCT01167894 Bioequivalence Study of Simvastatin Tablets 80 mg of Dr. Reddy's Under Fasting Condition | Healthy | P1 | Completed | 72 | RCT, Open-label | Simvastatin |
| NCT04885829 Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers | Rheumatoid Arthritis, Giant Cell Arteritis | P1 | Completed | 300 | RCT, Double-blind | Tocilizumab Prefilled Syringe |
| NCT06193187 A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions | Healthy Volunteers | P1 | Unknown | 48 | RCT, Open-label | Sacubitril and Valsartan Sodium Tablets 24 mg/26 mg, Entresto 50 mg |
| NCT01513044 Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fasting Conditions | Healthy | P1 | Completed | 68 | RCT, Open-label | Mycophenolate Mofetil, Mycophenolate Mofetil |
| NCT02322619 Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions | Healthy | P1 | Completed | 26 | RCT, Open-label | Moxifloxacin Tablets 400 mg |
| NCT01170169 Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fasting Conditions | Healthy | P1 | Completed | 44 | RCT, Open-label | Omeprazole, Prilosec |
| NCT01132027 Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddys's Laboratories Limited Under Non-Fasting Conditions | Healthy | P1 | Completed | 40 | RCT, Open-label | Tacrolimus Capsules |
| NCT01581775 Bioequivalence Study of Divalproex Sodium ER Tablets 500 mg of Dr. Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 54 | RCT, Open-label | Divalproex Sodium |
| NCT01056627 Bioequivalence Study of Dr. Reddy's Divalproex Sodium Coated Particles in Capsules, 125 mg, Under Fed Condition | Healthy | P1 | Completed | 34 | RCT, Open-label | Divalproex Sodium |
| NCT01146028 Bioequivalence Study of Tizanidine HCl Tablets 4 mg of Dr.Reddys Under Fasting Conditions | Healthy | P1 | Completed | 42 | RCT, Open-label | Tizanidine |
| NCT01505998 Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions | Fed | P1 | Completed | 49 | RCT, Open-label | Amlodipine Besylate/Benazepril HCl |
| NCT01045434 Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule Under Fed Conditions | Healthy | P1 | Completed | 62 | RCT, Open-label | Omeprazole |
| NCT01888757 Lamotrigine Extended-Release Tablets 50 mg Under Fed Condition | Healthy | P1 | Completed | 62 | RCT, Open-label | Lamotrigine |
| NCT02295046 Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition | Healthy | P1 | Completed | 80 | RCT, Open-label | Amlodipine besylate/Atorvastatin calcium |
| NCT01064102 Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition | Healthy | P1 | Completed | 30 | RCT, Open-label | Cetirizine Hydrochloride |
| NCT02291367 Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting Condition | Healthy | P1 | Completed | 76 | RCT, Open-label | Duloxetine, Cymbalta® |
| NCT01373138 Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-release Tablets Under Fasting Conditions | Healthy | P1 | Completed | 34 | RCT, Open-label | Desloratadine and pseudoephedrine |
| NCT01506037 Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fed Condition | Healthy | P1 | Completed | 36 | RCT, Open-label | Desloratadine |
| NCT02291341 Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed Condition | Healthy | P1 | Completed | 76 | RCT, Open-label | Duloxetine, Cymbalta® |
| NCT01888263 Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed Condition | Healthy | P1 | Completed | 32 | RCT, Open-label | Lamotrigine |
| NCT01671709 Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fasting Condition | Healthy | P1 | Completed | 41 | RCT, Open-label | Montelukast sodium |
| NCT01269281 Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed Conditions | Healthy | P1 | Completed | 50 | RCT, Open-label | Sumatriptan |
| NCT01283867 Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Non-Fasting Conditions | FED | P1 | Completed | 92 | RCT, Open-label | Mycophenolate Mofetil |
| NCT01671722 Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fed Condition | Healthy | P1 | Completed | 43 | RCT, Open-label | Montelukast sodium |
| NCT03696329 Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fasting Conditions | Healthy | P1 | Completed | 48 | RCT, Open-label | Tetrabenazine Tablets 25 mg |
| NCT01511770 Bioavailability Study of Fluconazole Tablets 200 mg Under Fasting Conditions | Healthy | P1 | Completed | 17 | RCT, Open-label | Fluconazole, Fluconazole |
| NCT01372345 Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions | Fasting | P1 | Completed | 43 | RCT, Open-label | CIPRO®XR |
| NCT01674504 Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fasting Condition | Healthy | P1 | Completed | 63 | RCT, Open-label | Montelukast sodium chewable tablets 4 mg and 5 mg |
| NCT01064115 Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition | Healthy | P1 | Completed | 30 | RCT, Open-label | Cetirizine Hydrochloride |
| NCT01160042 Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fasting Condition | Healthy | P1 | Completed | 54 | RCT, Open-label | Metformin, Glucophage |
| NCT01888731 Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fasting Condition | Healthy | P1 | Completed | 62 | RCT, Open-label | Lamotrigine |
| NCT01131767 Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER Tablets of Dr. Reddy's Under Fed Conditions | Healthy | P1 | Completed | 26 | RCT, Open-label | Naproxen Sodium & Pseudoephedrine HCl |
| NCT02062073 Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion | Head Lice | P1 | Completed | 238 | RCT, Double-blind | Abametapir Lotion 0.74% w/w |
| NCT01133483 Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr.Reddy's Under Fed Conditions | Healthy | P1 | Completed | 38 | RCT, Open-label | Fexofenadine HCl + Pseudoephedrine HCl |
| NCT01132170 Bioequivalency Study of Divalproex Sodium DR Tablets, 500 mg of Dr.Reddy's Under Fasting Conditions | Healthy | P1 | Completed | 34 | RCT, Open-label | Divalproex Sodium |
| NCT01504503 Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting Condition | Healthy | P1 | Completed | 26 | RCT, Open-label | Donepezil Hydrochloride, Aricept |
| NCT03051685 Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine Dose-proportionality of DFN-15 in Fasting Healthy Adults | Healthy | P1 | Completed | 16 | RCT, Open-label | DFN-15 Dose 1, DFN-15 Dose 2, DFN-15 Dose 3, Active Comparator |
| NCT02865161 Amtolmetin Gaucil in Knee Osteoarthritis | Knee Osteoarthritis | Completed | 220 | — | NISELAT | |
| NCT02711943 Non Interventional Study of Levofloxacin in Chronic Prostatitis | Chronic Prostatitis | Completed | 500 | — | Levofloxacin 500 | |
| NCT02712502 Levofloxacin in Bacterial Rhinosinussitis | Rhinosinusitis | Completed | 100 | — | Levofloxacin, Amoxicillin-Potassium Clavulanate Combination |